BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31280706)

  • 21. The Aachen Minipig: Phenotype, Genotype, Hematological and Biochemical Characterization, and Comparison to the Göttingen Minipig.
    Pawlowsky K; Ernst L; Steitz J; Stopinski T; Kögel B; Henger A; Kluge R; Tolba R
    Eur Surg Res; 2017; 58(5-6):193-203. PubMed ID: 28433992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Justification for species selection for pharmaceutical toxicity studies.
    Prior H; Haworth R; Labram B; Roberts R; Wolfreys A; Sewell F
    Toxicol Res (Camb); 2020 Dec; 9(6):758-770. PubMed ID: 33442468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Miniature Swine as a Model in Experimental and Translational Medicine.
    Stricker-Krongrad A; Shoemake CR; Bouchard GF
    Toxicol Pathol; 2016 Jun; 44(4):612-23. PubMed ID: 27073085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The minipig in dermatotoxicology: methods and challenges.
    Mahl JA; Vogel BE; Court M; Kolopp M; Roman D; Nogués V
    Exp Toxicol Pathol; 2006 Jul; 57(5-6):341-5. PubMed ID: 16713702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The minipig as a platform for new technologies in toxicology.
    Forster R; Ancian P; Fredholm M; Simianer H; Whitelaw B;
    J Pharmacol Toxicol Methods; 2010; 62(3):227-35. PubMed ID: 20685311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulatory acceptability of the minipig in the development of pharmaceuticals, chemicals and other products.
    van der Laan JW; Brightwell J; McAnulty P; Ratky J; Stark C;
    J Pharmacol Toxicol Methods; 2010; 62(3):184-95. PubMed ID: 20601024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Göttingen minipig in pharmacology and toxicology.
    Bollen P; Ellegaard L
    Pharmacol Toxicol; 1997; 80 Suppl 2():3-4. PubMed ID: 9249853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spontaneous glomerulonephritis in Göttingen minipigs.
    Vezzali E; Manno RA; Salerno D; Oberto G; Nyska A; Ramot Y
    Toxicol Pathol; 2011 Jun; 39(4):700-5. PubMed ID: 21628719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The RETHINK project: impact of toxicity testing in the minipig as an alternative approach in regulatory toxicity testing.
    Curtis MJ
    J Pharmacol Toxicol Methods; 2010; 62(3):157. PubMed ID: 20692353
    [No Abstract]   [Full Text] [Related]  

  • 30. Porcine Prediction of Pharmacokinetic Parameters in People: A Pig in a Poke?
    Tang H; Mayersohn M
    Drug Metab Dispos; 2018 Nov; 46(11):1712-1724. PubMed ID: 30171162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The minipig in toxicology.
    Svendsen O
    Exp Toxicol Pathol; 2006 Jul; 57(5-6):335-9. PubMed ID: 16725317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Application of the Tissue Composition-Based Model to Minipig for Predicting the Volume of Distribution at Steady State and Dermis-to-Plasma Partition Coefficients of Drugs Used in the Physiologically Based Pharmacokinetics Model in Dermatology.
    Poulin P; Collet SH; Atrux-Tallau N; Linget JM; Hennequin L; Wilson CE
    J Pharm Sci; 2019 Jan; 108(1):603-619. PubMed ID: 30222978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A shortened study design for embryo-fetal development studies in the minipig.
    Pique C; Marsden E; Quesada P; Blondel A; Mikkelsen LF
    Reprod Toxicol; 2018 Sep; 80():35-43. PubMed ID: 29940329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Shedding light on minipig drug metabolism - elevated amide hydrolysis in vitro.
    Jones R; Marschmann M; Keller M; Qiu NH; Fowler S; Singer T; Schuler F; Funk C; Schadt S
    Xenobiotica; 2016; 46(6):483-94. PubMed ID: 26405846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The minipig as a new model for the evaluation of doxorubicin-induced chronic toxicity.
    Manno RA; Grassetti A; Oberto G; Nyska A; Ramot Y
    J Appl Toxicol; 2016 Aug; 36(8):1060-72. PubMed ID: 26614124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of minipig, dog, monkey and human drug metabolism and disposition.
    Dalgaard L
    J Pharmacol Toxicol Methods; 2015; 74():80-92. PubMed ID: 25545337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Potential of the incredibly-small minipig for pharmacological safety studies].
    Akie Y
    Nihon Yakurigaku Zasshi; 2014 Mar; 143(3):156. PubMed ID: 24614640
    [No Abstract]   [Full Text] [Related]  

  • 38. Development of a Functional Observational Battery in the Minipig for Regulatory Neurotoxicity Assessments.
    Zhong M; Shoemake C; Fuller A; White D; Hanks C; Brocksmith D; Liu J; Gad S; Bouchard G; Stricker-Krongrad A
    Int J Toxicol; 2017; 36(2):113-123. PubMed ID: 28196426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Göttingen minipig® as an alternative non-rodent species for immunogenicity testing: a demonstrator study using the IL-1 receptor antagonist anakinra.
    van Mierlo GJ; Cnubben NH; Kuper CF; Wolthoorn J; van Meeteren-Kreikamp AP; Nagtegaal MM; Doornbos R; Ganderup NC; Penninks AH
    J Immunotoxicol; 2013; 10(1):96-105. PubMed ID: 23134195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The selection of marmoset monkeys (Callithrix jacchus) in pharmaceutical toxicology.
    Smith D; Trennery P; Farningham D; Klapwijk J
    Lab Anim; 2001 Apr; 35(2):117-30. PubMed ID: 11315160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.